Deutsche Bank
FLNA

Deutsche Bank’s Filana Therapeutics FLNA Stock Holding History

Deutsche Bank’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-34,615
Closed -$51.9K – 3719
2025
Q1 		$51.9K Sell
34,615
-1,956
-5% -$4.94K ﹤0.01% 3370
2024
Q4 		$86.3K Buy
36,571
+10,940
+43% +$192K ﹤0.01% 3325
2024
Q3 		$754K Buy
25,631
+6,314
+33% +$145K ﹤0.01% 2248
2024
Q2 		$239K Sell
19,317
-2,172
-10% -$45.8K ﹤0.01% 2710
2024
Q1 		$436K Buy
21,489
+342
+2% +$7.88K ﹤0.01% 2417
2023
Q4 		$476K Sell
21,147
-411
-2% -$8.68K ﹤0.01% 2415
2023
Q3 		$359K Buy
21,558
+1,271
+6% +$25.2K ﹤0.01% 2384
2023
Q2 		$497K Sell
20,287
-9,169
-31% -$221K ﹤0.01% 2378
2023
Q1 		$710K Buy
29,456
+8,006
+37% +$222K ﹤0.01% 2299
2022
Q4 		$634K Buy
21,450
+2,010
+10% +$72.2K ﹤0.01% 2320
2022
Q3 		$813K Sell
19,440
-4,306
-18% -$116K ﹤0.01% 2092
2022
Q2 		$667K Sell
23,746
-348
-1% -$8.79K ﹤0.01% 2423
2022
Q1 		$895K Sell
24,094
-2,124
-8% -$90K ﹤0.01% 2421
2021
Q4 		$1.15M Sell
26,218
-72,203
-73% -$3.79M ﹤0.01% 2355
2021
Q3 		$6.11M Buy
98,421
+72,437
+279% +$6.05M ﹤0.01% 1398
2021
Q2 		$2.22M Buy
25,984
+4,543
+21% +$243K ﹤0.01% 2129
2021
Q1 		$964K Sell
21,441
-1,494
-7% -$58.8K ﹤0.01% 2687
2020
Q4 		$156K Buy
22,935
+11,143
+94% +$99.5K ﹤0.01% 3608
2020
Q3 		$136K Buy
11,792
+1,124
+11% +$5.07K ﹤0.01% 3407
2020
Q2 		$33K Buy
+10,668
New +$48.4K ﹤0.01% 3967
2018
Q2 		– Sell
-20,632
Closed -$146K – 5585
2018
Q1 		$146K Buy
20,632
+20,226
+4,982% +$137K ﹤0.01% 4342
2017
Q4 		$1K Buy
406
+400
+6,667% +$1.61K ﹤0.01% 4951
2017
Q3 		$0 Sell
6
-805
-99% -$2.88K ﹤0.01% 5047
2017
Q2 		$3K Buy
+811
New +$3.83K ﹤0.01% 4803
2016
Q3 		– Sell
-13
Closed – – 5163
2016
Q2 		$0 Hold
13
– – ﹤0.01% 5323
2016
Q1 		$0 Sell
13
-642
-98% -$8.31K ﹤0.01% 5312
2015
Q4 		$8K Buy
+655
New +$8.67K ﹤0.01% 4973
2015
Q3 		– Sell
-542
Closed -$6K – 5313
2015
Q2 		$6K Sell
542
-142,317
-100% -$1.95M ﹤0.01% 5124
2015
Q1 		$1.89M Sell
142,859
-11
-0% -$148 ﹤0.01% 2479
2014
Q4 		$2.03M Sell
142,870
-39
-0% -$675 ﹤0.01% 2660
2014
Q3 		$3.91M Buy
142,909
+25
+0% +$760 ﹤0.01% 2013
2014
Q2 		$5.75M Sell
142,884
-927
-0.6% -$34.3K ﹤0.01% 1726
2014
Q1 		$5.54M Buy
143,811
+954
+0.7% +$33.7K ﹤0.01% 1743
2013
Q4 		$4.86M Sell
142,857
-11,761
-8% -$312K ﹤0.01% 1770
2013
Q3 		$2.94M Sell
154,618
-16,913
-10% -$296K ﹤0.01% 2212
2013
Q2 		$2.65M Buy
+171,531
New +$3.63M ﹤0.01% 2021

Other funds holding FLNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Deutsche Bank's FLNA Position: Q2 2025 in Review

Deutsche Bank sold out of Filana Therapeutics (FLNA) in Q2 2025, closing a stake of 34,615 shares — an estimated $51.9K sold.

Deutsche Bank first reported a position in FLNA in Q2 2013 and held it in 36 quarters. The position peaked at $6.11M in Q3 2021. 97 funds tracked by Wall St. Rank hold FLNA as of Q2 2025.

  • Deutsche Bank reported no remaining Filana Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Deutsche Bank sold 34,615 Filana Therapeutics shares in Q2 2025, an estimated $51.9K.
  • Deutsche Bank first reported a position in Filana Therapeutics in Q2 2013 and held it in 36 quarters.
  • Deutsche Bank's Filana Therapeutics position peaked at $6.11M in Q3 2021.
  • 97 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2025.

Based on Deutsche Bank's 13F filing for Q2 2025, filed 12 Aug 2025.